Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,120.00    -10.00 (-0.14%)
Bid:
7,115.00
Ask:
7,120.00
Spread: 5.00 (0.07%)
Market Cap: £9.55b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Update

24 Mar 2016 07:00

RNS Number : 0981T
Diploma PLC
24 March 2016
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

24 March 2016

 

 

DIPLOMA PLC

 

TRADING UPDATE

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update for the six months ending 31 March 2016, ahead of going into its close period.

 

Trading Summary

The businesses acquired during the past year have made a good contribution to the Group's overall results and revenues for the six months ending 31 March 2016 are expected to be ca. 9% ahead of the comparable period. The acquired businesses have contributed ca. 8% to Group revenues. Currency movements have reduced revenues by ca. 1%, despite the weakening of UK sterling since the beginning of the calendar year. On an underlying basis, after adjusting for the impact of currencies and acquisitions, revenues are expected to increase by 1-2%.

 

In the Life Sciences Sector, underlying revenues are expected to show good growth, with stronger capital equipment sales in certain businesses against weak comparatives. Reported revenues in Life Sciences will be broadly flat due to the impact of currency movements on translation of the results of the Healthcare businesses. In the Seals Sector, reported revenues will be substantially ahead of last year, reflecting the contribution from the businesses acquired during the past 12 months. On an underlying basis, revenues are likely to be broadly unchanged on the strong comparable period. In the Controls Sector, reported revenues are expected to be marginally up on the previous year, helped by strong growth in the Specialty Fastener business and with an initial contribution from the recent Cablecraft acquisition. The Interconnect and Fluid Controls businesses are beginning to stabilise but on an underlying basis Controls revenues are expected to be slightly below last year.

 

In Life Sciences, the impact on Healthcare gross margins from further depreciation of the Canadian and Australian dollars against the US dollar through 2015 has been partly mitigated by stronger gross margins in the Group's other businesses. Following a strong 18 month period for acquisitions, the initial lower operating margins in the acquired businesses, together with investments in these businesses have impacted the Group's operating margin at the Half Year which is expected to be ca. 100bps below the comparable period last year.

 

Financial Position

After spending ca. £31m on completing the acquisitions of WCIS in October 2015 and Cablecraft in early March 2016, the Group expects to have net debt of ca. £25m at 31 March 2016, compared with net cash balances of £3.0m at 30 September 2015. The Group currently has a committed revolving bank facility of £50m of which £40m has been drawn down.

 

The Group's Half Year results will be announced on Monday, 16 May 2016.

 

 

Notes:

 

1. This Trading Update, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC .It should not be relied on by any other party, for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

 

Our businesses then design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment.

 

The Group employs ca. 1,500 employees and its principal operating businesses are located in the UK, Northern Europe, North America and Australia.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 15% p.a. through a combination of organic growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. £850m.

 

 

 

Further information on Diploma PLC, together with a copy of this Announcement, is available at www.diplomaplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEXLFLQXFEBBD
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.